Black and White Women Who Received Neoadjuvant Therapy Were Equally Likely to Have Pathologic Complete Response
Tumor biology, not race, was a more significant factor in predicting response to clinical trial treatment SAN ANTONIO – Analysis...
Search/Filter
Loading...
Black Women are More Likely to Develop Lymphedema Following Breast Cancer Treatment than White Women
SAN ANTONIO – Black women experienced higher rates of breast cancer-related lymphedema than white women, and Black race was...
Elacestrant May Improve Outcomes for Patients Whose Metastatic Breast Cancers Progressed on Prior Endocrine Therapy
Elacestrant is the first oral selective estrogen receptor degrader to show clinical benefit over standard of care in a...
Single-cell Spatial Analysis May Help Predict Response to Neoadjuvant Immunotherapy in Triple-negative Breast Cancer
Imaging mass cytometry was feasible in a large clinical trial of atezolizumab in combination with chemotherapy SAN ANTONIO –...
Using Genomics to Match Treatments Improved Outcomes for Certain Patients With Metastatic Breast Cancer
The ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) was highly predictive of the benefits of targeted therapies...
Sequencing of Bone Marrow DNA May Predict Leukemia Relapse After CAR-T Therapy With Sufficient Time to Intervene
Next-generation sequencing for minimal residual disease was highly sensitive and more accurate than flow cytometry and monitoring of B-cell...
Call for Nominations: AACR and Pelotonia Announce New Scientific Achievement Awards for Women’s Cancers, funded by The Victoria’s Secret Global Fund for Women’s Cancers
PHILADELPHIA – Today, the American Association for Cancer Research (AACR) and Pelotonia announced the establishment of a new grants...
Fasting-mimicking Diet Is Safe, May Modulate Metabolism and Boost Antitumor Immunity in Cancer Patients
PHILADELPHIA – A diet involving short-term, severe calorie restriction was safe, feasible, and resulted in a decrease of blood...
AACR Applauds Nomination of Robert Califf, MD, as FDA Commissioner
AACR expresses appreciation to Janet Woodcock, MD, for her excellent stewardship as FDA’s Acting Commissioner for the past 10...
Award Winners Named for the 2021 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...